Estrogens’ beneficial effects extend to pulmonary arterial hypertension, where it mitigates the severity of the condition through mechanisms involving ERα, ERβ, and GPER, thereby promoting vasodilation and protecting against vascular remodeling [98,101,102]. This evidence concerns the gene ESR2 and pulmonary arterial hypertension.